These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
540 related items for PubMed ID: 31557565
1. In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli. Wang Y, Li H, Xie X, Wu X, Li X, Zhao Z, Luo S, Wan Z, Liu J, Fu L, Li X. J Glob Antimicrob Resist; 2020 Mar; 20():351-359. PubMed ID: 31557565 [Abstract] [Full Text] [Related]
2. Diclofenac Sodium Restores the Sensitivity of Colistin-Resistant Gram-Negative Bacteria to Colistin. Fu Q, Liu S, Hu P, Chen H, Zheng J, Shi S, Xu M, Zhou T, Sun Y. ACS Infect Dis; 2024 Aug 09; 10(8):2860-2869. PubMed ID: 39073350 [Abstract] [Full Text] [Related]
3. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. Lee CH, Tang YF, Su LH, Chien CC, Liu JW. Microb Drug Resist; 2008 Sep 09; 14(3):233-7. PubMed ID: 18707240 [Abstract] [Full Text] [Related]
4. In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase. Wei W, Yang H, Liu Y, Ye Y, Li J. J Chemother; 2016 Jun 09; 28(3):159-63. PubMed ID: 25978105 [Abstract] [Full Text] [Related]
5. Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains. O'Hara JA, Ambe LA, Casella LG, Townsend BM, Pelletier MR, Ernst RK, Shanks RM, Doi Y. Antimicrob Agents Chemother; 2013 May 09; 57(5):2103-8. PubMed ID: 23422916 [Abstract] [Full Text] [Related]
6. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis. Dinc G, Demiraslan H, Elmali F, Ahmed SS, Metan G, Alp E, Doganay M. Chemotherapy; 2013 May 09; 59(5):325-9. PubMed ID: 24525528 [Abstract] [Full Text] [Related]
7. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC, Choi JA, Jang SJ, Jeong SH, Kim CM, Choi IS, Kang SH, Park G, Moon DS. Ann Lab Med; 2016 Mar 09; 36(2):124-30. PubMed ID: 26709259 [Abstract] [Full Text] [Related]
9. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H, Kus H, Arslan U, Tuncer I. Mikrobiyol Bul; 2014 Apr 09; 48(2):311-5. PubMed ID: 24819268 [Abstract] [Full Text] [Related]
10. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii. Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, Bagheri KP. Eur J Clin Microbiol Infect Dis; 2018 Mar 09; 37(3):443-454. PubMed ID: 29353377 [Abstract] [Full Text] [Related]
12. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii. Ni W, Cui J, Liang B, Cai Y, Bai N, Cai X, Wang R. J Antibiot (Tokyo); 2013 Dec 09; 66(12):705-8. PubMed ID: 23981963 [Abstract] [Full Text] [Related]
13. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection. Principe L, Capone A, Mazzarelli A, D'Arezzo S, Bordi E, Di Caro A, Petrosillo N. Microb Drug Resist; 2013 Oct 09; 19(5):407-14. PubMed ID: 23659601 [Abstract] [Full Text] [Related]
14. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii. Dong X, Chen F, Zhang Y, Liu H, Liu Y, Ma L. J Antibiot (Tokyo); 2014 Sep 09; 67(9):677-80. PubMed ID: 25095805 [Abstract] [Full Text] [Related]
15. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method. Thamlikitkul V, Tiengrim S. J Med Assoc Thai; 2014 Mar 09; 97 Suppl 3():S1-6. PubMed ID: 24772574 [Abstract] [Full Text] [Related]
16. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates. Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B. J Chemother; 2012 Oct 09; 24(5):247-52. PubMed ID: 23182043 [Abstract] [Full Text] [Related]
17. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains]. Cıkman A, Ceylan MR, Parlak M, Karahocagil MK, Berktaş M. Mikrobiyol Bul; 2013 Jan 09; 47(1):147-51. PubMed ID: 23390912 [Abstract] [Full Text] [Related]
18. Restoring colistin sensitivity in colistin-resistant Salmonella and Escherichia coli: combinatorial use of berberine and EDTA with colistin. Cui X-d, Liu X-k, Ma X-y, Li S-h, Zhang J-k, Han R-j, Yi K-f, Liu J-h, Pan Y-s, He D-d, Hu G-z, Zhai Y-j. mSphere; 2024 Jun 25; 9(6):e0018224. PubMed ID: 38738873 [Abstract] [Full Text] [Related]
19. Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant Acinetobacter baumannii Using Checkerboard Information. Menegucci TC, Fedrigo NH, Lodi FG, Albiero J, Nishiyama SAB, Mazucheli J, Carrara-Marroni FE, Voelkner NMF, Gong H, Sy SKB, Tognim MCB. Microb Drug Resist; 2019 Nov 25; 25(9):1266-1274. PubMed ID: 31216222 [Abstract] [Full Text] [Related]
20. Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study. Gunalan A, Sarumathi D, Sastry AS, Ramanathan V, Rajaa S, Sistla S. Indian J Pharmacol; 2021 Nov 25; 53(3):207-212. PubMed ID: 34169905 [Abstract] [Full Text] [Related] Page: [Next] [New Search]